Clinical trial
A Study to Assess the Diagnostic Performance of 18F-Thretide PET/CT in Men With Prostate Cancer
NCT05516329 is registered in ClinicalTrials.gov with First Affiliated Hospital of Fujian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess the Diagnostic Performance of 18F-Thretide PET/CT in Men With Prostate Cancer
- Lead sponsor
- First Affiliated Hospital of Fujian Medical University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 20, 2022
- Completion date
- September 1, 2023
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer